Petra Hoffman

Let me begin by saying that one of the best things that has ever happened to me, is the fact that I was diagnosed with hepatitis C almost two years ago now.

I say that for a couple of reasons. One, is that now I know what has been wrong with me for quite some time now, and that it is not in my head, or a figment of my imagination. It allows me now, to be sick, when I am sick, instead of trying not to be, because I feel guilty. The other reason, is that since my initial diagnosis, I have put a higher value on life, and the world around me. I think that it is the first time I have seen many things.

I look at everything and everyone from a different angle now. For that, I am grateful.

I was not sure if I wanted to lay my life bare for all to see, and for all to know about. I have put my entire life and career on hold, and willingly have sacrificed it all. I’ve decided to go ahead with this because it is a way for me to get it out, and I hope to help others go through their journeys with less pain and embarrassment than necessary. It is my deepest desire to create public awareness and to educate mankind about hepatitis B and C. I truly believe that in order to raise awareness, we, the people who do know that we have it, must bypass the stigma, and lose the embarrassment, in order to help more people that do not as yet know that they are infected. We are the ones who have the knowledge, and it must be shared. It will take too long to rid ourselves of the stigma, and in BC alone there are upwards of 300 new cases every day. I beseech every one of you, to stand beside me in this campaign to educate the public. We need you to be strong and to be brave.

We need your voices, and we need your faces, as I cannot do this alone.

Share your story now

For people living with a hepatitis condition, it really helps to know they’re not alone. That’s why we’re inviting people to share their stories.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close